We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPD icon
101
Enterprise Products Partners
EPD
$82.1B
$128M 0.18%
4,430,016
+266,805
+6% +$7.69M
NEE icon
102
NextEra Energy
NEE
$176B
$127M 0.18%
2,471,928
+40,432
+2% +$1.99M
SHM icon
103
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.47B
$126M 0.18%
2,577,530
+144,383
+6% +$7.02M
SO icon
104
Southern Company
SO
$107B
$126M 0.18%
2,280,747
+20,312
+0.9% +$1.09M
LQD icon
105
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.9B
$124M 0.18%
994,601
+411,451
+71% +$49.4M
EFA icon
106
iShares MSCI EAFE ETF
EFA
$79.4B
$124M 0.18%
1,878,889
-56,000
-3% -$3.66M
TGT icon
107
Target
TGT
$66.9B
$122M 0.18%
1,412,934
-56,610
-4% -$4.57M
MMM icon
108
3M
MMM
$92.9B
$120M 0.17%
830,836
-24,111
-3% -$3.71M
IBM icon
109
IBM
IBM
$220B
$120M 0.17%
912,024
+35,998
+4% +$4.73M
TFC icon
110
Truist Financial
TFC
$64.4B
$120M 0.17%
2,443,060
-25,166
-1% -$1.23M
FVD icon
111
First Trust Value Line Dividend Fund
FVD
$8.38B
$118M 0.17%
3,499,391
+360,683
+11% +$11.9M
IVW icon
112
iShares S&P 500 Growth ETF
IVW
$77.2B
$118M 0.17%
2,624,564
+59,636
+2% +$2.62M
LIN icon
113
Linde
LIN
$226B
$115M 0.17%
572,898
-25,112
-4% -$4.7M
ORCL icon
114
Oracle
ORCL
$414B
$115M 0.17%
2,022,646
+68,654
+4% +$3.71M
AGN
115
DELISTED
Allergan plc
AGN
$115M 0.17%
686,679
-58,261
-8% -$8.07M
ADBE icon
116
Adobe
ADBE
$103B
$113M 0.16%
384,986
+9,449
+3% +$2.62M
ALL icon
117
Allstate
ALL
$70.6B
$113M 0.16%
1,114,625
-2,434
-0.2% -$238K
AMT icon
118
American Tower
AMT
$80B
$113M 0.16%
554,197
-10,779
-2% -$2.17M
VEU icon
119
Vanguard FTSE All-World ex-US ETF
VEU
$67.9B
$113M 0.16%
2,213,998
+133,272
+6% +$6.72M
WELL icon
120
Welltower
WELL
$170B
$113M 0.16%
1,383,441
-22,022
-2% -$1.73M
NVDA icon
121
NVIDIA
NVDA
$5.33T
$111M 0.16%
27,054,480
+317,320
+1% +$1.32M
FAST icon
122
Fastenal
FAST
$58.2B
$108M 0.16%
6,640,040
-2,182,136
-25% -$36M
VTV icon
123
Vanguard Morningstar Value ETF
VTV
$191B
$108M 0.16%
973,093
+227,506
+31% +$24.8M
SBUX icon
124
Starbucks
SBUX
$120B
$107M 0.15%
1,273,353
-265,530
-17% -$20.8M
XLV icon
125
State Street Health Care Select Sector SPDR ETF
XLV
$42.3B
$106M 0.15%
1,144,780
-16,065
-1% -$1.44M

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.